Maximus Reports Fourth Quarter and Full Year Results for Fiscal Year 2024

Establishes fiscal year 2025 guidance

TYSONS, Va.--(BUSINESS WIRE)-- Maximus (NYSE: MMS), a leading provider of government services worldwide, reported financial results for the three months and year ended September 30, 2024.

Highlights for the fourth quarter and full fiscal year 2024 include:

  • Full year revenue increased 8.2% to $5.31 billion, compared to $4.90 billion for the prior year. Organic growth was 8.8% and driven by higher volumes on key programs in the U.S. segments. Fourth quarter revenue grew 4.4%, or 4.7% on an organic basis.
  • Full year diluted earnings per share were $4.99, and adjusted diluted earnings per share were $6.11. Fourth quarter diluted earnings per share were $1.19, and adjusted diluted earnings per share were $1.46.
  • Full year cash flows from operating activities totaled $515 million, and free cash flow was $401 million, enabling debt reduction across the year to yield a 1.4x leverage ratio at September 30, 2024, as calculated in accordance with our credit agreement.
  • A quarterly cash dividend of $0.30 per share payable on November 30, 2024, to shareholders of record on November 15, 2024.

"We are proud of the team for an excellent finish to a strong year, and one that demonstrates a healthy core business operating within our margin expectations," said Bruce Caswell, President and Chief Executive Officer. "We kick off fiscal 2025 with guidance that blends the momentum of fiscal 2024 with thoughtfulness toward the upcoming U.S. Presidential transition."

Caswell continued, "Our earned position as an efficient and flexible partner to government in the administration of entitlement programs and essential government services perennially supported on a bipartisan basis positions us well to advise, adapt, and rapidly implement new priorities."

Consolidated Fiscal Year 2024 Fourth Quarter and Full Year Results

Revenue for the full fiscal year 2024 increased 8.2% to $5.31 billion, compared to $4.90 billion for the prior year. Organic growth was 8.8% over the prior year. Revenue for the fourth quarter of the fiscal year grew 4.4% to $1.32 billion, or 4.7% on an organic basis. Both periods benefited from volume growth on clinical programs in the U.S. Federal Services Segment. The U.S. Services Segment had a full fiscal year 2024 contribution of Medicaid redetermination activities that have returned to normal levels, plus excess volumes from Medicaid-related support activities that were concluded by the fourth quarter of fiscal year 2024.

For the full fiscal year 2024, the operating margin was 9.2% and the adjusted EBITDA margin was 11.6%. This compares to margins of 6.0% and 9.1%, respectively, for the prior year that reflected ramping volumes on core programs and a partial period contribution from resumed Medicaid-related activities. Adjusted EBITDA margin excludes divestiture-related charges which were not material in either fiscal year.

Earnings per share were $4.99 and adjusted diluted earnings per share were $6.11. This compares to $2.63 and $3.83, respectively, for the prior year. Fourth quarter diluted earnings per share were $1.19, and adjusted diluted earnings per share were $1.46. This compares to $0.96 and $1.29, respectively, for the prior-year period.

U.S. Federal Services Segment

U.S. Federal Services Segment revenue for fiscal year 2024 increased 13.9% to $2.74 billion, compared to $2.40 billion reported for the prior year. All growth was organic and driven primarily by volume growth on clinical programs.

The segment operating margin for the full fiscal year 2024 was 12.2%, as compared to 10.4% reported for the prior year. The segment delivered an 11.1% margin in fourth quarter of fiscal year 2024. Higher demand for services, particularly in clinical services, and a higher mix of performance-based work were drivers of margin enhancement in the segment this year.

U.S. Services Segment

U.S. Services Segment revenue for fiscal year 2024 increased by 5.5% to $1.91 billion, compared to $1.81 billion reported in the prior year. All growth was organic and driven by strong performance across the Medicaid-related portfolio. This included excess volumes from the unwinding exercise, which was concluded by the fourth quarter of this fiscal year.

The segment operating margin for fiscal year 2024 was 12.9%, compared to 10.1% reported in the prior year, and benefited from the strong Medicaid-related performance and the aforementioned excess volumes. The segment delivered an 11.1% margin in fourth quarter of fiscal year 2024 and did not benefit from excess volumes.

Outside the U.S. Segment

Outside the U.S. Segment revenue for fiscal year 2024 decreased 4.6% to $657.1 million as compared to $689.1 million reported for the prior year. Prior-year divestitures reduced revenue by 6.1%, while currency effects provided a 1.7% benefit to revenue growth.

The segment realized an operating profit of $7.7 million for fiscal year 2024, compared to an operating loss of $9.1 million in the prior year. Profitability for the segment this year, including the 4.8% margin in fourth quarter, reflects progress in containing volatile programs that have acted as greater headwinds in prior periods.

Sales, Pipeline, and Backlog

Year-to-date signed contract awards at September 30, 2024, totaled $2.2 billion, and contracts pending (awarded but unsigned) totaled $312 million. The book-to-bill ratio at September 30, 2024, was 0.4x on a trailing twelve-month basis. The lower book-to-bill reflects an anticipated lower-than-normal period of rebid activity. Given circumstances as best known today, the volume of adjudications for both rebids and new work are expected to increase over the next 12 months and result in an improved book-to-bill.

The sales pipeline at September 30, 2024, was $54.3 billion (comprised of approximately $4.22 billion in proposals pending, $7.12 billion in proposals in preparation, and $42.9 billion in opportunities tracking). New work opportunities represent approximately 48% of the total sales pipeline.

Backlog at September 30, 2024, which represents estimated future revenue from existing signed contracts, contracts that have been awarded but not yet signed, and unexercised priced contract options, was estimated to be $16.2 billion. This compares to $20.7 billion at the same point in the prior year. Remaining option periods for the Contact Center Operations (CCO) contract are included in the year-end balance, while the backlog associated with the Veterans Affairs Medical Disability Examination contracts has been reduced to account for the two-year recompete currently in the procurement stage.

Balance Sheet and Cash Flows

At September 30, 2024, cash and cash equivalents totaled $183 million, and gross debt was $1.15 billion. The ratio of debt, net of allowed cash, to consolidated EBITDA for the full year ended September 30, 2024, as calculated in accordance with our credit agreement, was 1.4x. At the same point in the prior year, the ratio was 2.2x, and we remain below our target leverage range of 2x to 3x.

For fiscal year 2024, cash flows from operating activities totaled $515 million, and free cash flow was $401 million. This compares to $314 million and $224 million, respectively, in the prior year. DSO at September 30, 2024, were 61 days, compared with 60 days at the same point in the prior year.

During fiscal year 2024, we purchased approximately 0.9 million shares totaling $73.1 million. Subsequent to September 30, 2024, and through November 19, 2024, we purchased approximately 0.5 million shares totaling $43.2 million. Including the subsequent activity, approximately $128 million remains on the current $200 million Board of Directors authorization granted in June 2024.

On October 5, 2024, our Board of Directors declared a quarterly cash dividend of $0.30 for each share of our common stock outstanding. The dividend is payable on November 30, 2024, to shareholders of record on November 15, 2024.

Fiscal Year 2025 Outlook

Maximus is establishing fiscal year 2025 guidance. Revenue is expected to range between $5.275 billion and $5.425 billion. An adjusted EBITDA margin, which excludes divestiture-related charges, of approximately 11.0% is anticipated for the full year. Adjusted diluted earnings per share, which excludes expense for amortization of intangible assets and divestiture-related charges, is expected to range between $5.70 and $6.00 per share.

Free cash flow is expected to range between $345 million and $375 million for fiscal year 2025. Forecasted expense of $92 million for amortization of intangible assets, $45 million for depreciation and amortization, and $65 million for interest is anticipated for the full year. An effective income tax rate of approximately 25% and weighted average shares outstanding of about 61 million is expected for fiscal year 2025.

Conference Call and Webcast Information

Maximus will host a conference call tomorrow, November 21, 2024, at 9:00 a.m. ET. Shareholders are invited to submit questions for management’s consideration by emailing IR@maximus.com up to one hour prior to the call.

The call is open to the public and available by webcast or by phone at:
877.407.8289 (Domestic) / +1.201.689.8341 (International)

For those unable to listen to the live call, a recording of the webcast will be available on investor.maximus.com.

About Maximus

As a leading strategic partner to governments across the globe, Maximus helps improve the delivery of public services amid complex technology, health, economic, environmental, and social challenges. With a deep understanding of program service delivery, acute insights that achieve operational excellence, and an extensive awareness of the needs of the people being served, our employees advance the critical missions of our partners. Maximus delivers innovative business process management, impactful consulting services, and technology solutions that provide improved outcomes for the public and higher levels of productivity and efficiency of government-sponsored programs. For more information, visit maximus.com.

Non-GAAP Measures and Risk Factors

This release refers to non-GAAP measures and other indicators, including organic growth, free cash flow, operating income, and EPS adjusted for amortization of intangible assets and divestiture-related charges, adjusted EBITDA, and other non-GAAP measures.

A description of these non-GAAP measures, the reasons why we use and present them, and details as to how they are calculated are included in our earnings presentation and forthcoming Form 10-K.

The presentation of these non-GAAP numbers is not meant to be considered in isolation, nor as alternatives to cash flows from operations, revenue growth, or net income as measures of performance. These non-GAAP financial measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

Statements that are not historical facts, including statements about the company’s confidence and strategies, and the company’s expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand, or acceptance of the company’s products are forward-looking statements that involve risks and uncertainties.

These risks could cause the company’s actual results to differ materially from those indicated by such forward-looking statements. A summary of risk factors can be found in Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the year ended September 30, 2024, expected to be filed shortly with the Securities and Exchange Commission (SEC). The Company's SEC reports are accessible on maximus.com.

 

 

FY25 Guidance Reconciliation - Non-GAAP

($ in millions except per share items)

Low End

 

High End

Operating income

$

439

 

 

$

464

 

Add: amortization of intangible assets

 

92

 

 

 

92

 

Add: depreciation & amortization of property, equipment and capitalized software

 

45

 

 

 

45

 

Add: divestiture-related charges

 

 

 

 

 

Adjusted EBITDA

$

576

 

 

$

601

 

Revenue

$

5,275

 

 

$

5,425

 

Adjusted EBITDA Margin

 

10.9

%

 

 

11.1

%

 

 

 

 

Diluted EPS

$

4.60

 

 

$

4.90

 

Add: effect of amortization of intangible assets on diluted EPS

 

1.10

 

 

 

1.10

 

Add: divestiture-related charges

 

 

 

 

 

Adjusted diluted EPS

$

5.70

 

 

$

6.00

 

 

 

 

 

Cash flows from operating activities

$

435

 

 

$

465

 

Remove: purchases of property and equipment and capitalized software costs

 

(90

)

 

 

(90

)

Free cash flow

$

345

 

 

$

375

 

 
 
 
 

Maximus, Inc.
Consolidated Statements of Operations
(Unaudited)
 

 

 

For the Three Months Ended

September 30,

 

For the Year Ended

September 30,

 

 

2024

 

 

2023

 

 

2024

 

 

2023

 

(in thousands, except per share amounts)

Revenue

$

1,315,870

 

 

$

1,259,953

 

$

5,306,197

 

 

$

4,904,728

Cost of revenue

 

1,014,175

 

 

 

969,059

 

 

4,054,545

 

 

 

3,876,120

Gross profit

 

301,695

 

 

 

290,894

 

 

1,251,652

 

 

 

1,028,608

Selling, general, and administrative expenses

 

166,901

 

 

 

167,778

 

 

671,583

 

 

 

639,223

Amortization of intangible assets

 

23,038

 

 

 

23,992

 

 

91,570

 

 

 

94,591

Operating income

 

111,756

 

 

 

99,124

 

 

488,499

 

 

 

294,794

Interest expense

 

20,012

 

 

 

20,507

 

 

82,440

 

 

 

84,138

Other (income)/expense, net

 

(925

)

 

 

442

 

 

(450

)

 

 

363

Income before income taxes

 

92,669

 

 

 

78,175

 

 

406,509

 

 

 

210,293

Provision for income taxes

 

20,165

 

 

 

19,029

 

 

99,595

 

 

 

48,501

Net income

$

72,504

 

 

$

59,146

 

$

306,914

 

 

$

161,792

 

 

 

 

 

 

 

 

Earnings per share:

 

 

 

 

 

 

 

Basic

$

1.20

 

 

 

0.97

 

$

5.03

 

 

$

2.65

Diluted

$

1.19

 

 

 

0.96

 

$

4.99

 

 

$

2.63

Weighted average shares outstanding:

 

 

 

 

 

 

 

Basic

 

60,553

 

 

 

61,138

 

 

61,049

 

 

 

61,125

Diluted

 

61,085

 

 

 

61,617

 

 

61,484

 

 

 

61,450

 

 

 

 

 

 

 

 

Dividends declared per share

$

0.30

 

 

$

0.28

 

$

1.20

 

 

$

1.12

 
 
 
 

Maximus, Inc.
Consolidated Balance Sheets
(Unaudited)
 

 

 

As of September 30,

 

 

2024

 

 

 

2023

 

 

(in thousands)

Assets:

 

 

 

Cash and cash equivalents

$

183,123

 

 

$

65,405

 

Accounts receivable, net

 

879,514

 

 

 

826,873

 

Income taxes receivable

 

5,282

 

 

 

16,556

 

Prepaid expenses and other current assets

 

132,625

 

 

 

146,632

 

Total current assets

 

1,200,544

 

 

 

1,055,466

 

Property and equipment, net

 

38,977

 

 

 

38,831

 

Capitalized software, net

 

187,677

 

 

 

107,811

 

Operating lease right-of-use assets

 

133,594

 

 

 

163,929

 

Goodwill

 

1,782,871

 

 

 

1,779,215

 

Intangible assets, net

 

630,569

 

 

 

703,648

 

Deferred contract costs, net

 

59,432

 

 

 

45,372

 

Deferred compensation plan assets

 

55,913

 

 

 

42,919

 

Deferred income taxes

 

14,801

 

 

 

2,459

 

Other assets

 

27,130

 

 

 

46,147

 

Total assets

$

4,131,508

 

 

$

3,985,797

 

Liabilities and Shareholders' Equity:

 

 

 

Liabilities:

 

 

 

Accounts payable and accrued liabilities

$

303,321

 

 

$

282,081

 

Accrued compensation and benefits

 

237,121

 

 

 

194,251

 

Deferred revenue, current portion

 

83,238

 

 

 

60,477

 

Income taxes payable

 

26,535

 

 

 

451

 

Long-term debt, current portion

 

40,139

 

 

 

86,844

 

Operating lease liabilities, current portion

 

47,656

 

 

 

49,852

 

Other current liabilities

 

69,519

 

 

 

49,058

 

Total current liabilities

 

807,529

 

 

 

723,014

 

Deferred revenue, non-current portion

 

45,077

 

 

 

38,849

 

Deferred income taxes

 

169,118

 

 

 

203,898

 

Long-term debt, non-current portion

 

1,091,954

 

 

 

1,163,149

 

Deferred compensation plan liabilities, non-current portion

 

57,599

 

 

 

46,432

 

Operating lease liabilities, non-current portion

 

97,221

 

 

 

129,367

 

Other liabilities

 

20,195

 

 

 

13,253

 

Total liabilities

 

2,288,693

 

 

 

2,317,962

 

Shareholders' equity:

 

 

 

Common stock, no par value; 100,000 shares authorized; 60,352 and 60,998 shares issued and outstanding as of September 30, 2024 and 2023, respectively

 

598,304

 

 

 

577,898

 

Accumulated other comprehensive loss

 

(32,460

)

 

 

(27,615

)

Retained earnings

 

1,276,971

 

 

 

1,117,552

 

Total shareholders' equity

 

1,842,815

 

 

 

1,667,835

 

Total liabilities and shareholders' equity

$

4,131,508

 

 

$

3,985,797

 

 
 
 
 

Maximus, Inc.
Consolidated Statements of Cash Flows
(Unaudited)
 

 

 

For the Three Months Ended

September 30,

 

For the Year Ended

September 30,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

 

(in thousands)

Cash flows from operating activities:

 

 

 

 

 

 

 

Net income

$

72,504

 

 

$

59,146

 

 

$

306,914

 

 

$

161,792

 

Adjustments to reconcile net income to cash flows from operations:

 

 

 

 

 

 

 

Depreciation and amortization of property, equipment and capitalized software

 

9,811

 

 

 

17,633

 

 

 

33,957

 

 

 

54,725

 

Amortization of intangible assets

 

23,038

 

 

 

23,992

 

 

 

91,570

 

 

 

94,591

 

Amortization of debt issuance costs and debt discount

 

635

 

 

 

601

 

 

 

3,534

 

 

 

2,837

 

Deferred income taxes

 

(32,252

)

 

 

(823

)

 

 

(36,022

)

 

 

1,552

 

Stock compensation expense

 

7,744

 

 

 

7,283

 

 

 

35,349

 

 

 

29,522

 

Loss on sale of businesses

 

 

 

 

 

 

 

1,018

 

 

 

883

 

Change in assets and liabilities, net of effects of business combinations and disposals:

 

 

 

 

 

 

 

Accounts receivable

 

(24,034

)

 

 

(31,076

)

 

 

(50,562

)

 

 

(23,401

)

Prepaid expenses and other current assets

 

(8,751

)

 

 

(20,242

)

 

 

10,565

 

 

 

859

 

Deferred contract costs

 

(4,778

)

 

 

443

 

 

 

(13,155

)

 

 

2,688

 

Accounts payable and accrued liabilities

 

19,926

 

 

 

814

 

 

 

18,267

 

 

 

17,729

 

Accrued compensation and benefits

 

59,290

 

 

 

44,262

 

 

 

38,247

 

 

 

12,650

 

Deferred revenue

 

10,455

 

 

 

19,624

 

 

 

28,534

 

 

 

(12,123

)

Income taxes

 

21,729

 

 

 

16,228

 

 

 

32,305

 

 

 

(16,958

)

Operating lease right-of-use assets and liabilities

 

225

 

 

 

1,707

 

 

 

(1,906

)

 

 

(2,035

)

Other assets and liabilities

 

8,292

 

 

 

4,997

 

 

 

16,643

 

 

 

(10,971

)

Net cash provided by operating activities

 

163,834

 

 

 

144,589

 

 

 

515,258

 

 

 

314,340

 

Cash flows from investing activities:

 

 

 

 

 

 

 

Purchases of property and equipment and capitalized software

 

(31,953

)

 

 

(31,832

)

 

 

(114,190

)

 

 

(90,695

)

Asset acquisition

 

7

 

 

 

 

 

 

(17,999

)

 

 

 

Proceeds from divestitures

 

7

 

 

 

608

 

 

 

3,085

 

 

 

9,732

 

Net cash used in investing activities

 

(31,939

)

 

 

(31,224

)

 

 

(129,104

)

 

 

(80,963

)

Cash flows from financing activities:

 

 

 

 

 

 

 

Cash dividends paid to Maximus shareholders

 

(18,054

)

 

 

(17,020

)

 

 

(72,901

)

 

 

(68,073

)

Purchases of Maximus common stock

 

(25,794

)

 

 

 

 

 

(73,069

)

 

 

 

Tax withholding related to RSU vesting

 

 

 

 

 

 

 

(13,455

)

 

 

(8,475

)

Payments for contingent consideration

 

 

 

 

(2,769

)

 

 

(10,977

)

 

 

(9,431

)

Payments for debt financing costs

 

 

 

 

 

 

 

(9,724

)

 

 

 

Proceeds from borrowings

 

250,000

 

 

 

161,901

 

 

 

1,100,166

 

 

 

844,299

 

Principal payments for debt

 

(259,377

)

 

 

(222,460

)

 

 

(1,212,202

)

 

 

(952,974

)

Cash-collateralized escrow liabilities

 

7,398

 

 

 

(1,601

)

 

 

16,516

 

 

 

(56,144

)

Net cash used in financing activities

 

(45,827

)

 

 

(81,949

)

 

 

(275,646

)

 

 

(250,798

)

Effect of exchange rate changes on cash, cash equivalents, and restricted cash

 

1,894

 

 

 

(1,018

)

 

 

3,164

 

 

 

2,717

 

Net change in cash, cash equivalents, and restricted cash

 

87,962

 

 

 

30,398

 

 

 

113,672

 

 

 

(14,704

)

Cash, cash equivalents and restricted cash, beginning of period

 

147,801

 

 

 

91,693

 

 

 

122,091

 

 

 

136,795

 

Cash, cash equivalents and restricted cash, end of period

$

235,763

 

 

$

122,091

 

 

$

235,763

 

 

$

122,091

 

 
 
 
 

Maximus, Inc.
Consolidated Results of Operations by Segment
(Unaudited)
 

 

 

For the Three Months Ended

September 30,

 

For the Year Ended

September 30,

 

2024

 

2023

 

2024

 

2023

 

Amount

 

% (1)

 

Amount

 

% (1)

 

Amount

 

% (1)

 

Amount

 

% (1)

 

(dollars in thousands)

Revenue:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Federal Services

$

675,117

 

 

 

 

$

617,404

 

 

 

 

$

2,737,244

 

 

 

 

$

2,403,606

 

 

 

U.S. Services

 

463,555

 

 

 

 

 

473,827

 

 

 

 

 

1,911,813

 

 

 

 

 

1,812,069

 

 

 

Outside the U.S.

 

177,198

 

 

 

 

 

168,722

 

 

 

 

 

657,140

 

 

 

 

 

689,053

 

 

 

Revenue

$

1,315,870

 

 

 

 

$

1,259,953

 

 

 

 

$

5,306,197

 

 

 

 

$

4,904,728

 

 

 

Gross profit:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Federal Services

$

159,688

 

 

23.7%

 

$

155,373

 

 

25.2%

 

$

665,762

 

 

24.3%

 

$

557,886

 

 

23.2%

U.S. Services

 

110,290

 

 

23.8%

 

 

109,389

 

 

23.1%

 

 

479,787

 

 

25.1%

 

 

377,541

 

 

20.8%

Outside the U.S.

 

31,717

 

 

17.9%

 

 

26,132

 

 

15.5%

 

 

106,103

 

 

16.1%

 

 

93,181

 

 

13.5%

Gross profit

$

301,695

 

 

22.9%

 

$

290,894

 

 

23.1%

 

$

1,251,652

 

 

23.6%

 

$

1,028,608

 

 

21.0%

Selling, general, and administrative expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Federal Services

$

84,469

 

 

12.5%

 

$

78,606

 

 

12.7%

 

$

332,140

 

 

12.1%

 

$

308,197

 

 

12.8%

U.S. Services

 

58,773

 

 

12.7%

 

 

54,198

 

 

11.4%

 

 

232,805

 

 

12.2%

 

 

194,991

 

 

10.8%

Outside the U.S.

 

23,149

 

 

13.1%

 

 

26,375

 

 

15.6%

 

 

98,398

 

 

15.0%

 

 

102,311

 

 

14.8%

Divestiture related charges (2)

 

 

 

NM

 

 

2,868

 

 

NM

 

 

1,018

 

 

NM

 

 

3,751

 

 

NM

Other (3)

 

510

 

 

NM

 

 

5,731

 

 

NM

 

 

7,222

 

 

NM

 

 

29,973

 

 

NM

Selling, general, and administrative expenses

$

166,901

 

 

12.7%

 

$

167,778

 

 

13.3%

 

$

671,583

 

 

12.7%

 

$

639,223

 

 

13.0%

Operating income/(loss):

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

U.S. Federal Services

$

75,219

 

 

11.1%

 

$

76,767

 

 

12.4%

 

$

333,622

 

 

12.2%

 

$

249,689

 

 

10.4%

U.S. Services

 

51,517

 

 

11.1%

 

 

55,191

 

 

11.6%

 

 

246,982

 

 

12.9%

 

 

182,550

 

 

10.1%

Outside the U.S.

 

8,568

 

 

4.8%

 

 

(243

)

 

(0.1)%

 

 

7,705

 

 

1.2%

 

 

(9,130

)

 

(1.3)%

Amortization of intangible assets

 

(23,038

)

 

NM

 

 

(23,992

)

 

NM

 

 

(91,570

)

 

NM

 

 

(94,591

)

 

NM

Divestiture related charges (2)

 

 

 

NM

 

 

(2,868

)

 

NM

 

 

(1,018

)

 

NM

 

 

(3,751

)

 

NM

Other (3)

 

(510

)

 

NM

 

 

(5,731

)

 

NM

 

 

(7,222

)

 

NM

 

 

(29,973

)

 

NM

Operating income

$

111,756

 

 

8.5%

 

$

99,124

 

 

7.9%

 

$

488,499

 

 

9.2%

 

$

294,794

 

 

6.0%

(1)

Percentage of respective segment revenue. Percentages not considered meaningful are marked "NM."

(2)

During fiscal years 2024 and 2023, we sold a number of businesses in our Outside the U.S. Segment.

(3)

Other includes credits and costs that are not allocated to a particular segment, including charges related to acquisitions, divestitures, and certain legal activities. For fiscal year 2023, these included charges of $29.3 million related to a previously disclosed cybersecurity incident.

 
 
 
 

Maximus, Inc.
Consolidated Free Cash Flows - Non-GAAP
(Unaudited)
 

 

 

For the Three Months Ended

September 30,

 

For the Year Ended

September 30,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

 

(in thousands)

Net cash provided by operating activities

$

163,834

 

 

$

144,589

 

 

$

515,258

 

 

$

314,340

 

Purchases of property and equipment and capitalized software

 

(31,953

)

 

 

(31,832

)

 

 

(114,190

)

 

 

(90,695

)

Free cash flow

$

131,881

 

 

$

112,757

 

 

$

401,068

 

 

$

223,645

 

 
 
 
 

Maximus, Inc.
Non-GAAP Adjusted Results - Operating Income, Adjusted EBITDA, Net Income, and Diluted Earnings per Share
(Unaudited)
 

 

 

For the Three Months Ended

September 30,

 

For the Year Ended

September 30,

 

 

2024

 

 

 

2023

 

 

 

2024

 

 

 

2023

 

 

(dollars in thousands, except per share data)

Operating income

$

111,756

 

 

$

99,124

 

 

$

488,499

 

 

$

294,794

 

Add back: Amortization of intangible assets

 

23,038

 

 

 

23,992

 

 

 

91,570

 

 

 

94,591

 

Add back: Divestiture-related charges

 

 

 

 

2,868

 

 

 

1,018

 

 

 

3,751

 

Adjusted operating income excluding amortization of intangible assets and divestiture-related charges (Non-GAAP)

$

134,794

 

 

$

125,984

 

 

$

581,087

 

 

$

393,136

 

Adjusted operating income margin excluding amortization of intangible assets and divestiture-related charges (Non-GAAP)

 

10.2

%

 

 

10.0

%

 

 

11.0

%

 

 

8.0

%

 

 

 

 

 

 

 

 

Add back: Depreciation and amortization of property, equipment, and capitalized software

 

9,811

 

 

 

17,633

 

 

 

33,957

 

 

 

54,725

 

Adjusted EBITDA (Non-GAAP)

$

144,605

 

 

$

143,617

 

 

$

615,044

 

 

$

447,861

 

Adjusted EBITDA margin (Non-GAAP)

 

11.0

%

 

 

11.4

%

 

 

11.6

%

 

 

9.1

%

 

 

 

 

 

 

 

 

Net income

$

72,504

 

 

$

59,146

 

 

$

306,914

 

 

$

161,792

 

Add back: Amortization of intangible assets, net of tax

 

16,973

 

 

 

17,682

 

 

 

67,481

 

 

 

69,714

 

Add back: Divestiture-related charges

 

 

 

 

2,868

 

 

 

1,018

 

 

 

3,751

 

Adjusted net income excluding amortization of intangible assets and divestiture-related charges (Non-GAAP)

$

89,477

 

 

$

79,696

 

 

$

375,413

 

 

$

235,257

 

 

 

 

 

 

 

 

 

Diluted earnings per share

$

1.19

 

 

$

0.96

 

 

$

4.99

 

 

$

2.63

 

Add back: Effect of amortization of intangible assets on diluted earnings per share

 

0.27

 

 

 

0.28

 

 

 

1.10

 

 

 

1.14

 

Add back: Effect of divestiture-related charges on diluted earnings per share

 

 

 

 

0.05

 

 

 

0.02

 

 

 

0.06

 

Adjusted diluted earnings per share excluding amortization of intangible assets and divestiture-related charges (Non-GAAP)

$

1.46

 

 

$

1.29

 

 

$

6.11

 

 

$

3.83

 

 
 

 

James Francis, VP - IR
Jessica Batt, VP - IR & ESG
IR@maximus.com

Source: Maximus